Foresite Capital Management IV, LLC Diversified Active

Name: Foresite Capital Management IV, LLC Q1 2018 13F Filing | 13F Explorer
Creator: Foresite Capital Management IV, LLC
Published: 2018-05-15

Location: West Hollywood, CA

CIK: 0001704132 · Show all filings

Period: Q1 2018 (← Previous) (Next →)

Filing Date: May 15, 2018

Total Value: $241M (100.0% shares, 0.0% debt)

Holdings (18)

INSM Insmed Incorporated 16.8%

Value $40.52M Shares 1,799,225 Est. Cost $27.89 Unrealized -5.7%

ASND Ascendis Pharma A/S 12.9%

Value $31.09M Shares 475,419 Est. Cost $40.06 Unrealized —

— CymaBay Therapeutics, Inc. 11.4%

Value $27.43M Shares 2,111,869 Est. Cost $9.20 Unrealized —

— Biohaven Pharmaceutical Holding Company Ltd. 9.1%

Value $21.93M Shares 851,200 Est. Cost $26.07 Unrealized —

— Myokardia, Inc. 7.9%

Value $19.13M Shares 391,955 Est. Cost $43.51 Unrealized —

— Immunomedics, Inc. 6.5%

Value $15.68M Shares 1,073,272 Est. Cost $16.16 Unrealized —

QURE uniQure N.V. 5.5%

Value $13.16M Shares 560,073 Est. Cost $15.23 Unrealized +43.2%

— Alder BioPharmaceuticals, Inc. 4.4%

Value $10.55M Shares 830,919 Est. Cost $12.35 Unrealized —

RCUS Arcus Biosciences, Inc. 4.2%

Value $10.04M Shares 650,000 Est. Cost $16.66 Unrealized 0.0%

— OptiNose, Inc. 4.0%

Value $9.682M Shares 483,606 Est. Cost $18.98 Unrealized —

— Alder BioPharmaceuticals, Inc. 3.3%

Value $7.9M Shares 450,000 Est. Cost — Unrealized —

ACRS Aclaris Therapeutics, Inc. 3.1%

Value $7.526M Shares 429,551 Est. Cost $23.05 Unrealized -8.0%

ABUS Arbutus Biopharma Corporation 3.1%

Value $7.426M Shares 1,485,245 Est. Cost $5.35 Unrealized -1.1%

— Insmed Incorporated 2.8%

Value $6.8M Shares 300,000 Est. Cost — Unrealized —

— Myokardia, Inc. 2.0%

Value $4.9M Shares 100,000 Est. Cost — Unrealized —

RYTM Rhythm Pharmaceuticals, Inc. 1.7%

Value $3.98M Shares 200,000 Est. Cost $26.42 Unrealized +0.5%

— Ra Pharmaceuticals, Inc. 1.0%

Value $2.39M Shares 450,000 Est. Cost $5.31 Unrealized —

— Solid Biosciences Inc. 0.4%

Value $1.052M Shares 140,332 Est. Cost $7.50 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
INSM	Insmed Incorporated	1,799,225	$40.52M	16.8%	$27.89	-5.7%	COM	457669307
ASND	Ascendis Pharma A/S	475,419	$31.09M	12.9%	$40.06	—	SPONSORED ADR	04351P101
—	CymaBay Therapeutics, Inc.	2,111,869	$27.43M	11.4%	$9.20	—	COM	23257D103
—	Biohaven Pharmaceutical Holding Company Ltd.	851,200	$21.93M	9.1%	$26.07	—	COM	G11196105
—	Myokardia, Inc.	391,955	$19.13M	7.9%	$43.51	—	COM	62857M105
—	Immunomedics, Inc.	1,073,272	$15.68M	6.5%	$16.16	—	COM	452907108
QURE	uniQure N.V.	560,073	$13.16M	5.5%	$15.23	+43.2%	SHS	N90064101
—	Alder BioPharmaceuticals, Inc.	830,919	$10.55M	4.4%	$12.35	—	COM	014339105
RCUS	Arcus Biosciences, Inc.	650,000	$10.04M	4.2%	$16.66	0.0%	COM	03969F109
—	OptiNose, Inc.	483,606	$9.682M	4.0%	$18.98	—	COM	68404V100
—	Alder BioPharmaceuticals, Inc.	450,000	$7.9M	3.3%	—	—	Put	014339955
ACRS	Aclaris Therapeutics, Inc.	429,551	$7.526M	3.1%	$23.05	-8.0%	COM	00461U105
ABUS	Arbutus Biopharma Corporation	1,485,245	$7.426M	3.1%	$5.35	-1.1%	COM	03879J100
—	Insmed Incorporated	300,000	$6.8M	2.8%	—	—	Put	457669957
—	Myokardia, Inc.	100,000	$4.9M	2.0%	—	—	Put	62857M955
RYTM	Rhythm Pharmaceuticals, Inc.	200,000	$3.98M	1.7%	$26.42	+0.5%	COM	76243J105
—	Ra Pharmaceuticals, Inc.	450,000	$2.39M	1.0%	$5.31	—	COM	74933V108
—	Solid Biosciences Inc.	140,332	$1.052M	0.4%	$7.50	—	COM	83422E105